GUFIC BIOSCIENCES LTD. - 509079 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Pursuant to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, please find enclosed herewith the letter received from M/s. Link Intime India Private Limited, Registrar and Share Transfer Agent (RTA) of the Company for the quarter ended June 30, 2022. Kindly take the same on your record. GUFIC BIOSCIENCES LTD. - 509079 - Statement Of Investor Complaints For The Quarter Ended June 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- AMI SHAHDesignation :- Company Secretary and Compliance Officer GUFIC BIOSCIENCES LTD. - 509079 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Pursuant to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, please find enclosed herewith the letter received from M/s. Link Intime India Private Limited, Registrar and Share Transfer Agent (RTA) of the Company for the quarter ended March 31, 2022. Kindly take the same on your record. GUFIC BIOSCIENCES LTD. - 509079 - Closure of Trading Window
Pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015 as amended from time to time and the Company's Code of Conduct framed under the said provisions , the Trading Window for dealing in securities of the Company shall remain closed for all the Insiders (including Directors and Connected/ Designated Persons and their immediate relatives) from Friday, July 01, 2022 till 48 hours after the declaration of Un-Audited Financial Results of the Company for the quarter ended June 30, 2022. The date of meeting of the Board of Directors to consider and approve the Un- Audited Financial Results of the Company for the quarter ended June 30, 2022 will be informed in due course. Kindly take the same on record. GUFIC BIOSCIENCES LTD. - 509079 - Announcement under Regulation 30 (LODR)-Change in Directorate
In compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 , this is to inform you that based on recommendation of Nomination & Remuneration Committee and subject to approval of members at the ensuing Annual General Meeting, the Board of Directors ('Board') of the Company on June 28, 2022 vide resolution by circulation, have approved re-appointment of Dr. Rabi Sahoo (DIN: 01237464) as an Independent Director of the Company, whose current term expires on June 28, 2022, for the second term of two years commencing from June 29, 2022 to June 28, 2024. GUFIC BIOSCIENCES LTD. - 509079 - Announcement under Regulation 30 (LODR)-Credit Rating
Pursuant to Regulation 30(6) read with Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that M/s. ICRA Limited, a Credit Rating Agency, has revised (upgraded) its ratings on the bank facilities of the Company which is attached herewith. GUFIC BIOSCIENCES LTD. - 509079 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to the provisions of Regulation 30(6) read with Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, we would like to inform you that the officials of the Company will be meeting Investors/Analysts (Participants) as per the details enclosed herewith. GUFIC BIOSCIENCES LTD. - 509079 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed herewith a press release being issued by the Company on the captioned subject, the content of which is self-explanatory. The same is submitted for public dissemination and for your records. GUFIC BIOSCIENCES LTD. - 509079 - Disclosure Of Related Party Transactions Under Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed copy of disclosure pertaining to Related Party Transactions of the Company for the half year ended March 31, 2022. Kindly take the same on record. GUFIC BIOSCIENCES LTD. - 509079 - Completion Of Sale Of Equity Shares Of The Company By The Promoter In The Open Market For Achieving Minimum Public Shareholding
In furtherance to our intimation letter dated June 01, 2022, we wish to inform you that on June 02, 2022, Mr. Jayesh P. Choksi, Promoter of the Company, has sold/divested 4,68,000 equity shares constituting to around 0.48% of the paid up share capital of the Company having face value of Re. 1/- each through open market sale in accordance with SEBI Circular No. SEBl/HO/CFD/CMD/CIR/P/43/2018 dated February 22, 2018. Consequent to the aforementioned open market sale, the Company has complied with the minimum public shareholding requirements as mandated under rules 19(2)(b) and 19A of the Securities Contracts (Regulation) Rules, 1957 read with regulation 38 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.